msl-s1-web

Laboratoires de taille moyenne

Les solutions fiables de Mindray peuvent aider les laboratoires de taille moyenne à optimiser leur flux de travail, améliorer leur efficacité et maintenir un fonctionnement robuste.

Solution pour les laboratoires de taille moyenne

L’immunoessai par chimiluminescent
L’immunoessai par chimiluminescent
Les solutions d’immunoessais par chimiluminescents de Mindray associent des conceptions robustes avec les technologies de pointe les plus récentes pour permettre aux laboratoires de toutes tailles d'obtenir des résultats fiables et exacts. La grande qualité des réactifs d’immunoessais de Mindray permet d'obtenir des résultats sûrs avec une exactitude et une performance éprouvées, ce qui contribue à réduire les répétitions de test inutiles. De plus, la solution de immunoessais de Mindray simplifie le déroulement de l'analyse et réduit les interventions manuelles dans les laboratoires cliniques de tous types.
Chimie
Chimie
Mindray propose diverses solutions évolutives de chimie clinique pour répondre aux besoins des différents laboratoires. Nos systèmes de chimie avec traçabilité aident les laboratoires à obtenir des résultats exacts et comparables. De plus, le flux de travail simple et perfectionné peut maximiser la rentabilité et réduire le délai d'exécution. Nous offrons également la possibilité de combiner la biochimie et l’immunoessai en une ligne automatisée d'analyse de sérum pour encore améliorer la productivité.
Hématologie
Hématologie
Les produits d'hématologie de Mindray constituent désormais des solutions fiables et éprouvées sur le marché mondial. Nous offrons des solutions complètes pour toutes les tailles de laboratoire, des plus petits aux plus grands. Grâce à des technologies innovantes et à une attention portée à la grande qualité, nous fournissons des résultats fiables et exacts pour aider les médecins à poser des diagnostics exacts. En outre, nos systèmes d'automatisation flexibles permettent aux professionnels de laboratoire de choisir la solution optimale pour améliorer leur flux de travail et réduire les délais d'exécution.

Ressources

HemaBook | Hématologie | Disease screening | Hemabook
Hemabook Chapter 19: Have You Noticed Neutrophil Inclusions in the Thrombocytopenia Smear?
Hemabook | HemaBook
HemaBook Chapter 1 - 18
HemaBook | Hématologie | Hemabook
Hemabook Chapter 18: PLT-H: A new parameter for accurate platelet counting with anti-interference ability
Hématologie | HemaBook | Hemabook
Hemabook Chapter 17: The Clinical Significance of All-in-one CBC Plus ESR Analysis
In the last two chapters, we talked about what ESR is and the applications of ESR, CRP and CBC analysis. ESR is an acute phase reactant and serves as a marker for inflammation. It correlates with disease activity and response to therapy. We understand that single tests are not adequate to confirm any diagnosis, but they do give us important clues.
Hématologie | HemaBook | Hemabook
Hemabook Chapter 16: Where Do You Find Maurer Pigments?
According to the World Health Organization (WHO), there were an estimated 241 million cases of malaria worldwide in 2020, and the estimated number of malaria deaths stood at 627,000 in that year. The African Region was home to 95% of malaria cases and 96% of malaria deaths.
Hématologie | HemaBook | Hemabook
Hemabook Chapter 15: Applications of CBC, ESR and CRP Analysis, Part B
Blood, urine and feces analysis are the three common tests in clinical laboratories. Among them, blood testing is the most important way to keep track of one’s overall physical well-being.
Hématologie | Diagnostics in vitro | HemaBook | Hemabook | HemaBook
HemaBook Chapter 14: Quick Facts About Erythrocyte Sedimentation Rate (ESR)
The erythrocyte sedimentation rate (ESR), which is determined by the Westergren method, measures how quickly red blood cells (RBCs) settle at the bottom of a blood sample tube in millimeters (mm) in one hour.
Hématologie | Flux de travail optimal | HemaBook | Hemabook
HemaBook Chapter 13: Capture the Truth About Cell Morphology
Many laboratories are troubled by problems such as lengthy analysis processes and less efficient microscopic examinations due to lacking of experts in cell morphology and inadequate equipment. This makes them hard to reach a 30% overall re-exam rate, a target recommended by the international consensus group for hematology review.
Hématologie | HemaBook | Hemabook
HemaBook Chapter 12: A Clearer Truth? Find it Faster!
In the laboratory, what is the most common reason for you to gather with colleagues to look at and discuss samples or patient results on the screen or in a report?
Hématologie | HemaBook | Hemabook
HemaBook Chapter 11: A 'Sherlock Holmes' Helps You to Capture the Culprit of Diseases
A 43-year-old woman presented with persistent fever for two months. She had visited different hospitals more than three times, but there was no significant improvement in her symptoms. After being admitted to a top-tier hospital in China, she underwent a series of examinations.
Hématologie | HemaBook | Hemabook | COVID-19
Hemabook Chapter 10: How Digital Morphology Systems Help Labs Optimize Their Workflow?
Nowadays, hematology analyzers are used widely in laboratories to automatically count and differentiate blood cells. Nevertheless, blood morphology examination for the presence of abnormal cells is still the ‘gold standard’ in the routine blood count. Microscopic examination is the most valuable procedure in the laboratory, which can suggest some disorders previously identified by the analyzer.
HemaBook | Hemabook | Hématologie | COVID-19
HemaBook Chapter 9: How Does Eosinophil Count Change in COVID-19 Patient
Is prophylactic anticoagulant therapy a common treatment for clinicians to deal with thrombotic events in COVID-19? Is there a connection between the eosinophil count and anticoagulation monitoring in COVID-19 patients?
Hématologie | Diagnostics in vitro | Hemabook | Diagnostic en laboratoire | Diagnostic en laboratoire | BC-6800Plus | BC-6800 | BC-6000 | Covid 19 | HemaBook
HemaBook Chapter 8: Have You Noticed the Changes of Red Blood Cells in COVID-19?
As of January 26th, 2021, the coronavirus disease 2019 (COVID-19) pandemic has affected over 100 million people worldwide. Vaccination would help improve the situation in future.
Hématologie | Diagnostics in vitro | Hemabook | Diagnostic en laboratoire | Diagnostic en laboratoire | C3100 | C3510 | Covid 19 | HemaBook
HemaBook Chapter 7: How D-dimer in Coagulation Correlates with COVID-19?
As COVID-19 continues to swipe around the world, rapid diagnosis as well as prognosis and treatment of the COVID-19 patients has become an equally important topic among clinicians. Recently scientists have discovered that COVID-19 has a host cell receptor, Angiotensin Converting Enzyme II or ACE2.
Hématologie | Diagnostics in vitro | Hemabook | Diagnostic en laboratoire | Diagnostic en laboratoire | HemaBook
HemaBook Chapter 6: Mindray's solution for solving in-vitro PLT aggregation
EDTA-dependent pseudothrombocytopenia (EDTA-PTCP) induced by EDTA anticoagulants is a common laboratory phenomenon. It is caused by in-vitro PLT aggregation and may lead to a low PLT result and, ultimately, misdiagnosis and wrong medical treatment for the patient.
Hématologie | Diagnostics in vitro | Hemabook | Diagnostic en laboratoire | Diagnostic en laboratoire | CAL 8000 (NOUVEAU) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook
HemaBook Chapter 5: How Mindray Counts Low Platelets Correctly
Derived from megakaryocytes, platelets (PLT) are produced and matured in the bone marrow. Besides widely known thrombosis and wound repair, PLT also plays important roles in inflammation, immunity and cancer biology.
Hématologie | Diagnostics in vitro | Diagnostic en laboratoire | Diagnostic en laboratoire | CAL 8000 (NOUVEAU) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook | Hemabook
HemaBook Chapter 4: Is Platelet Transfusion Always Required in Thrombocytopenia?
When the platelet (PLT) count is extremely low, is platelet transfusion really required? Let’s analyze the following case, which tells us a different answer.
Hématologie | Diagnostics in vitro | Diagnostic en laboratoire | Diagnostic en laboratoire | AACC | CAL 8000 (NOUVEAU) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook | Hemabook
HemaBook Chapter 3: Resolve your concerns about the risk of low-value PLT measurements
When the platelet value is low, patients are at risk of bleeding. Bleeding in vital organs is life-threatening. According to Giuseppe Lippi and other professors, there is no universal agreement on the definition of platelet transfusion thresholds.
Hématologie | Diagnostics in vitro | Diagnostic en laboratoire | Diagnostic en laboratoire | AACC | CAL 8000 (NOUVEAU) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6800 | HemaBook | Hemabook
HemaBook Chapter 2: One More Option to Solve EDTA-PTCP?
Ethylenediaminetetraacetic Acid - Pseudothrombocytopenia (EDTA-PTCP) is a laboratory artifact that may lead to an incorrect evaluation and unnecessary treatment of patients.
Hématologie | Diagnostics in vitro | Diagnostic en laboratoire | Diagnostic en laboratoire | AACC | CAL 8000 (NOUVEAU) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook | Hemabook
HemaBook Chapter 1: The Stories of Platelet Clump
Thrombocytopenia is a condition characterized by abnormally low levels of platelets in the blood. However, falsely low platelet counts, or pseudothrombocytopenia (PTCP), though easily unrecognized, are found in clinical cases. It is an in vitro phenomenon caused by platelet clumping that results in reporting of a spuriously low platelet count by automatic hematology analyzers.
Voir plus